Mark Eisner

Mark Eisner

Company: Sonoma Biotherapeutics

Job title: Chief Medical Officer


Engineering Treg Approaches to Promote Immune Tolerance in Autoimmune Disease 8:30 am

Using CAR-Treg cell therapy approaches for autoimmune diseases including rheumatoid arthritis Translational data supporting 7101 CAR Treg as a therapeutic approach Demonstrating proof-of-mechanism for the immune tolerance strategyRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.